Mobile

A Phase IV, Multi-Center, Active-Controlled, Observer-Blind Study to Evaluate the Safety of a Trivalent Subunit Influenza Vaccine Produced either in Mammalian Cell Culture (Optaflu®) or in Embryonated...

Mise à jour : Il y a 4 ans
Référence : EUCTR2007-002872-32

A Phase IV, Multi-Center, Active-Controlled, Observer-Blind Study to Evaluate the Safety of a Trivalent Subunit Influenza Vaccine Produced either in Mammalian Cell Culture (Optaflu®) or in Embryonated Hen Eggs (Agrippal®) in Adults and Elderly With and Without Underlying Medical Conditions, and to Evaluate the Immunogenicity in a Subset of Subjects With Underlying Medical Conditions

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

Safety Objective To compare the safety of a single intramuscular (IM) dose of the cell-derived influenza subunit vaccine (Optaflu®) with that of the egg-derived influenza subunit vaccine (Agrippal®) in adult and elderly subjects with and without underlying conditions.

Critère d'inclusion

  • No medical condition, healthy subjects

Liens